| Escherichia coli |
Escherichia coli |
Activity |
nan |
None |
10.1128/aac.00014-10 |
| Escherichia coli |
Escherichia coli |
Inhibition |
nan |
% |
10.1128/aac.00014-10 |
| Homo sapiens |
5637 |
Activity |
nan |
None |
10.1128/aac.00014-10 |
| Homo sapiens |
Acetylcholinesterase |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2b adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2c adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Androgen Receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
ATP-binding cassette sub-family G member 2 |
Drug transport |
nan |
None |
10.1124/dmd.111.041731 |
| Homo sapiens |
Beta-2 adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bile salt export pump |
AC50 |
300000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bile salt export pump |
IC50 |
133000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Canalicular multispecific organic anion transporter 1 |
Activity |
68.0 |
% |
10.1021/jm7015683 |
| Homo sapiens |
Canalicular multispecific organic anion transporter 1 |
Drug transport |
nan |
None |
10.1124/dmd.111.041731 |
| Homo sapiens |
Canalicular multispecific organic anion transporter 1 |
IC50 |
133000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Canalicular multispecific organic anion transporter 1 |
Inhibition |
nan |
% |
10.1124/dmd.111.041731 |
| Homo sapiens |
Canalicular multispecific organic anion transporter 2 |
Activity |
nan |
None |
10.1124/dmd.111.041731 |
| Homo sapiens |
Canalicular multispecific organic anion transporter 2 |
IC50 |
133000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Canalicular multispecific organic anion transporter 2 |
Inhibition |
nan |
% |
10.1124/dmd.111.041731 |
| Homo sapiens |
Canalicular multispecific organic anion transporter 2 |
Km |
2500000.0 |
nM |
10.1124/dmd.111.041731 |
| Homo sapiens |
Canalicular multispecific organic anion transporter 2 |
Vmax |
0.6 |
nmol/min |
10.1124/dmd.111.041731 |
| Homo sapiens |
Cannabinoid CB1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cyclooxygenase-1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Delta opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
AC50 |
21000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Galactocerebrosidase |
Potency |
631.0 |
nM |
None |
| Homo sapiens |
Gamma-aminobutyric acid receptor subunit alpha-1/alpha-2/beta-2/gamma-2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Geminin |
Potency |
163.6 |
nM |
None |
| Homo sapiens |
HERG |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
-42.57 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
-0.57 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Homo sapiens |
Activity |
1.0 |
% |
10.1016/j.ejmech.2009.11.034 |
| Homo sapiens |
Homo sapiens |
CL |
0.2 |
mL.min-1.kg-1 |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
CL |
2.5 |
mL.min-1.kg-1 |
10.1021/jm900403j |
| Homo sapiens |
Homo sapiens |
CL |
2.5 |
mL.min-1.kg-1 |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
CL_renal |
2.3 |
mL.min-1.kg-1 |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
CL_renal |
2.33 |
mL.min-1.kg-1 |
10.1021/jm900403j |
| Homo sapiens |
Homo sapiens |
DILI_Concern |
nan |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
Homo sapiens |
DILI_severity_class |
7.0 |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
Homo sapiens |
Fa |
1.0 |
None |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
F_fraction |
0.95 |
None |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
Fg |
0.96 |
None |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
Fh |
0.99 |
None |
10.1021/jm901371v |
| Homo sapiens |
Homo sapiens |
Vdss |
0.23 |
L.kg-1 |
10.1021/jm901371v |
| Homo sapiens |
Kappa opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Monoamine oxidase A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Multidrug resistance-associated protein 1 |
Activity |
nan |
None |
10.1124/dmd.111.041731 |
| Homo sapiens |
Multidrug resistance-associated protein 1 |
Km |
3900000.0 |
nM |
10.1124/dmd.111.041731 |
| Homo sapiens |
Multidrug resistance-associated protein 1 |
Vmax |
12.4 |
nmol/min |
10.1124/dmd.111.041731 |
| Homo sapiens |
Multidrug resistance-associated protein 4 |
Activity |
nan |
None |
10.1124/dmd.111.041731 |
| Homo sapiens |
Multidrug resistance-associated protein 4 |
IC50 |
133000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Multidrug resistance-associated protein 4 |
Inhibition |
nan |
% |
10.1124/dmd.111.041731 |
| Homo sapiens |
Multidrug resistance-associated protein 4 |
Km |
250000.0 |
nM |
10.1124/dmd.111.041731 |
| Homo sapiens |
Multidrug resistance-associated protein 4 |
Vmax |
1.2 |
nmol/min |
10.1124/dmd.111.041731 |
| Homo sapiens |
Mu opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Norepinephrine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Oligopeptide transporter small intestine isoform |
Activity |
27.0 |
% |
10.1074/jbc.270.12.6456 |
| Homo sapiens |
Oligopeptide transporter small intestine isoform |
Activity |
nan |
None |
10.1006/bbrc.1998.9298 |
| Homo sapiens |
Oligopeptide transporter small intestine isoform |
Activity |
nan |
None |
10.1038/nrd3028 |
| Homo sapiens |
Oligopeptide transporter small intestine isoform |
Activity |
nan |
None |
10.2133/dmpk.17.253 |
| Homo sapiens |
Oligopeptide transporter small intestine isoform |
IC50 |
870000.0 |
nM |
10.1074/jbc.270.43.25672 |
| Homo sapiens |
Oligopeptide transporter small intestine isoform |
IC50 |
5400000.0 |
nM |
10.1074/jbc.270.43.25672 |
| Homo sapiens |
Oligopeptide transporter small intestine isoform |
Ki |
1450000.0 |
nM |
None |
| Homo sapiens |
Oligopeptide transporter small intestine isoform |
Ki |
7200000.0 |
nM |
10.1016/j.ejpb.2004.07.008 |
| Homo sapiens |
Oligopeptide transporter small intestine isoform |
Ki |
7200000.0 |
nM |
10.1021/jm048982w |
| Homo sapiens |
Oligopeptide transporter small intestine isoform |
Ki |
9100000.0 |
nM |
None |
| Homo sapiens |
Phosphodiesterase 3A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4D |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Progesterone receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 3a (5-HT3a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Solute carrier family 15 member 2 |
Activity |
0.0 |
% |
10.1016/0005-2736(95)80036-f |
| Homo sapiens |
Solute carrier family 15 member 2 |
Activity |
nan |
None |
10.1038/nrd3028 |
| Homo sapiens |
Solute carrier family 15 member 2 |
IC50 |
66000.0 |
nM |
10.1074/jbc.270.43.25672 |
| Homo sapiens |
Solute carrier family 15 member 2 |
Ki |
2500.0 |
nM |
10.1074/jbc.270.43.25672 |
| Homo sapiens |
Solute carrier family 15 member 2 |
Ki |
2800.0 |
nM |
10.1074/jbc.270.43.25672 |
| Homo sapiens |
Solute carrier family 15 member 2 |
Ki |
3000.0 |
nM |
10.1016/j.bmc.2011.06.027 |
| Homo sapiens |
Solute carrier family 15 member 2 |
Ki |
3019.95 |
nM |
10.1016/j.bmc.2011.06.027 |
| Homo sapiens |
Solute carrier family 22 member 5 |
Activity |
nan |
None |
10.1074/jbc.275.3.1699 |
| Homo sapiens |
Solute carrier family 22 member 6 |
Ki |
6140.0 |
nM |
10.1016/s0014-2999(02)01306-7 |
| Homo sapiens |
Solute carrier family 22 member 8 |
Inhibition |
20.0 |
% |
10.1124/dmd.112.049569 |
| Homo sapiens |
Solute carrier family 22 member 8 |
Ki |
8620.0 |
nM |
10.1016/s0014-2999(02)01306-7 |
| Homo sapiens |
Solute carrier family 22 member 8 |
Ki |
8620.0 |
nM |
10.1124/dmd.112.049569 |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B1 |
Inhibition |
9.4 |
% |
10.1021/jm300212s |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B1 |
Inhibition |
88.52 |
% |
10.1124/mol.112.084152 |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B3 |
Inhibition |
21.0 |
% |
10.1021/jm300212s |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B3 |
Inhibition |
101.2 |
% |
10.1124/mol.112.084152 |
| Homo sapiens |
Solute carrier organic anion transporter family member 2B1 |
Inhibition |
3.5 |
% |
10.1021/jm300212s |
| Homo sapiens |
Thrombin |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thromboxane A2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Mus musculus |
Intestine |
Drug uptake |
nan |
None |
10.1124/dmd.111.041731 |
| Mus musculus |
Jejunum |
Drug transport |
50.0 |
% |
10.1124/dmd.111.041731 |
| Mus musculus |
Jejunum |
Drug transport |
nan |
None |
10.1124/dmd.111.041731 |
| Mus musculus |
Kidney |
Drug uptake |
nan |
None |
10.1124/dmd.111.041731 |
| Mus musculus |
Liver |
Drug uptake |
nan |
None |
10.1124/dmd.111.041731 |
| Mus musculus |
Solute carrier family 22 member 6 |
Inhibition |
nan |
% |
10.1124/dmd.112.049569 |
| Mus musculus |
Solute carrier family 22 member 8 |
Inhibition |
nan |
% |
10.1124/dmd.112.049569 |
| Mus musculus |
Solute carrier family 22 member 8 |
PPB |
nan |
% |
10.1124/dmd.112.049569 |
| Rattus norvegicus |
GABA receptor alpha-1 subunit |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Glutamate (NMDA) receptor subunit zeta 1 |
AC50 |
23000.1 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Oligopeptide transporter, kidney isoform |
Ki |
3000.0 |
nM |
10.1016/j.ejpb.2004.07.008 |
| Rattus norvegicus |
Oligopeptide transporter, kidney isoform |
Ki |
3000.0 |
nM |
10.1152/ajprenal.1997.273.5.f706 |
| Rattus norvegicus |
Plasma |
Fu |
0.39 |
None |
10.1021/jm901371v |
| Rattus norvegicus |
Solute carrier family 15 member 1 |
Activity |
nan |
None |
10.1111/j.2042-7158.1997.tb06115.x |
| Rattus norvegicus |
Solute carrier family 15 member 1 |
Ki |
2170000.0 |
nM |
10.1152/ajprenal.1997.273.5.f706 |
| Rattus norvegicus |
Solute carrier family 22 member 5 |
Activity |
nan |
None |
10.1074/jbc.275.3.1699 |
| Rattus norvegicus |
Solute carrier family 22 member 6 |
Activity |
nan |
None |
None |
| Rattus norvegicus |
Solute carrier family 22 member 6 |
IC50 |
2000000.0 |
nM |
10.1016/s0024-3205(02)01500-x |
| Rattus norvegicus |
Solute carrier family 22 member 8 |
IC50 |
1780000.0 |
nM |
10.1016/s0024-3205(02)01500-x |
| Rattus norvegicus |
Solute carrier family 22 member 8 |
IC50 |
1780000.0 |
nM |
10.1124/dmd.112.049569 |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
14.01 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Hit score |
0.046 |
None |
10.1101/2020.04.21.054387 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
0.07 |
% |
10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
31.91 |
% |
10.21203/rs.3.rs-23951/v1 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition index |
0.02715 |
None |
10.1101/2020.04.03.023846 |
| Staphylococcus aureus |
Staphylococcus aureus |
IC50 |
312.0 |
ug.mL-1 |
10.1016/j.bmcl.2012.07.016 |
| None |
ADMET |
CL |
2.5 |
mL.min-1.kg-1 |
10.1124/dmd.108.020479 |
| None |
ADMET |
CL |
3.0 |
uL.min-1.(10^6cells)-1 |
10.6019/CHEMBL3301361 |
| None |
ADMET |
Drug excretion |
nan |
None |
10.1124/dmd.111.041731 |
| None |
ADMET |
Drug uptake |
0.4 |
% |
10.1124/dmd.111.041731 |
| None |
ADMET |
MRT |
1.5 |
hr |
10.1124/dmd.108.020479 |
| None |
ADMET |
Ratio |
3.0 |
None |
10.1124/dmd.111.041731 |
| None |
ADMET |
Ratio |
6.0 |
None |
10.1124/dmd.111.041731 |
| None |
ADMET |
T1/2 |
1.1 |
hr |
10.1124/dmd.108.020479 |
| None |
ADMET |
Vdss |
0.23 |
L.kg-1 |
10.1124/dmd.108.020479 |
| None |
Hepatotoxicity |
Alkaline Phosphatase Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Alkaline Phosphatase Increase - Index Value |
0.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Alkaline Phosphatase Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Composite Activity - Active |
0.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Composite Activity - Marginal |
0.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Composite Activity - Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
GGT Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
GGT Increase - Index Value |
0.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
GGT Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Hepatotoxicity |
nan |
None |
10.1021/tx1000865 |
| None |
Hepatotoxicity |
Hepatotoxicity |
nan |
None |
10.1021/tx900326k |
| None |
Hepatotoxicity |
Hepatotoxicity |
nan |
None |
10.1124/dmd.110.035113 |
| None |
Hepatotoxicity |
HepSE_bilirubinemia |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholecystitis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholelithiasis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cirrhosis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_Combined Scores |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_elevated liver function tests |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic failure |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic necrosis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatitis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatomegaly |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_jaundice |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver disease |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver fatty |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver function tests abnormal |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
LDH Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
LDH Increase - Index Value |
0.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
LDH Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGOT Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGOT Increase - Index Value |
0.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGOT Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGPT Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGPT Increase - Index Value |
0.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGPT Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
NON-PROTEIN TARGET |
Fu |
0.39 |
None |
10.1124/dmd.108.020479 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (acute) |
0.0 |
% |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (animal toxicity known) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (benign tumour) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (granulomatous hepatitis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (mechanism) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (moderate) |
1.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (moderate) |
3.1 |
% |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (time to onset) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
No relevant target |
LogD7.4 |
-0.86 |
None |
10.6019/CHEMBL3301361 |
| None |
Unchecked |
Ac50 |
0.3162 |
uM |
None |
| None |
Unchecked |
Ac50 |
5.012 |
uM |
None |
| None |
Unchecked |
Ac50 |
6.31 |
uM |
None |
| None |
Unchecked |
Ac50 |
8.913 |
uM |
None |
| None |
Unchecked |
Ac50 |
39.81 |
uM |
None |
| None |
Unchecked |
AC50 |
316.2 |
nM |
None |
| None |
Unchecked |
AC50 |
5011.9 |
nM |
None |
| None |
Unchecked |
AC50 |
6309.6 |
nM |
None |
| None |
Unchecked |
AC50 |
8912.5 |
nM |
None |
| None |
Unchecked |
AC50 |
39820.0 |
nM |
None |
| None |
Unchecked |
Hepatotoxicity (acute) |
2.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (association with vascular disease) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (choleostasis) |
2.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (chronic liver disease) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (cirrhosis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (comment) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (cytolytic) |
1.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (malignant tumour) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (severe hepatitis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (steatosis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (successful reintroduction) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Potency |
15848.9 |
nM |
None |